These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, Mizutani K, Deguchi T, Ito M. BMC Cancer; 2017 May 05; 17(1):316. PubMed ID: 28476099 [Abstract] [Full Text] [Related]
3. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, Mirshahidi S, Mercola D, Lilly MB, Wall NR. PLoS One; 2012 May 05; 7(10):e46737. PubMed ID: 23091600 [Abstract] [Full Text] [Related]
4. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment. Hosseini-Beheshti E, Choi W, Weiswald LB, Kharmate G, Ghaffari M, Roshan-Moniri M, Hassona MD, Chan L, Chin MY, Tai IT, Rennie PS, Fazli L, Tomlinson Guns ES. Oncotarget; 2016 Mar 22; 7(12):14639-58. PubMed ID: 26840259 [Abstract] [Full Text] [Related]
5. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma. Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee SW, Lee J, Ahn BC. Theranostics; 2017 Mar 22; 7(10):2732-2745. PubMed ID: 28819459 [Abstract] [Full Text] [Related]
6. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M. Thromb Haemost; 2005 May 22; 93(5):964-75. PubMed ID: 15886816 [Abstract] [Full Text] [Related]
7. Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment. Li Q, Hu J, Shi Y, Xiao M, Bi T, Wang C, Yan L, Li X. Cell Cycle; 2021 Dec 22; 20(23):2531-2546. PubMed ID: 34724861 [Abstract] [Full Text] [Related]
8. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Xue M, Chen W, Xiang A, Wang R, Chen H, Pan J, Pang H, An H, Wang X, Hou H, Li X. Mol Cancer; 2017 Aug 25; 16(1):143. PubMed ID: 28841829 [Abstract] [Full Text] [Related]
9. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, Inoue M, Yoshioka Y, Tsutsumi Y, Katayama S, Inoue M, Tsunoda S. Pharmazie; 2013 Dec 25; 68(12):969-73. PubMed ID: 24400444 [Abstract] [Full Text] [Related]
10. Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression. Philley JV, Kannan A, Qin W, Sauter ER, Ikebe M, Hertweck KL, Troyer DA, Semmes OJ, Dasgupta S. J Cell Physiol; 2016 Jun 25; 231(6):1364-74. PubMed ID: 26530043 [Abstract] [Full Text] [Related]
11. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Paša-Tolić L, Jenster G. PLoS One; 2013 Jun 25; 8(12):e82589. PubMed ID: 24391718 [Abstract] [Full Text] [Related]
12. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Liu P, Wang W, Wang F, Fan J, Guo J, Wu T, Lu D, Zhou Q, Liu Z, Wang Y, Shang Z, Chan FL, Yang W, Li X, Zhao SC, Zheng Q, Wang F, Wu D. J Transl Med; 2023 Jan 21; 21(1):40. PubMed ID: 36681849 [Abstract] [Full Text] [Related]
13. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer. Li W, Lu Y, Yu X, Yong M, Ma D, Gao Q. J Cell Biochem; 2019 Apr 21; 120(4):6361-6369. PubMed ID: 30304550 [Abstract] [Full Text] [Related]
14. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population. Matijašević Joković S, Korać A, Kovačević S, Djordjević A, Filipović L, Dobrijević Z, Brkušanin M, Savić-Pavićević D, Vuković I, Popović M, Brajušković G. Int J Mol Sci; 2024 Mar 21; 25(6):. PubMed ID: 38542507 [Abstract] [Full Text] [Related]
15. Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer. Li S, Zhao Y, Chen W, Yin L, Zhu J, Zhang H, Cai C, Li P, Huang L, Ma P. J Cancer; 2018 Mar 21; 9(15):2659-2665. PubMed ID: 30087706 [Abstract] [Full Text] [Related]
16. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715 [Abstract] [Full Text] [Related]
17. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer. Wu W, Yang Q, Fung KM, Humphreys MR, Brame LS, Cao A, Fang YT, Shih PT, Kropp BP, Lin HK. Mol Cell Endocrinol; 2014 Mar 05; 383(1-2):69-79. PubMed ID: 24296312 [Abstract] [Full Text] [Related]
18. Exosomal miRNAs as biomarkers of recurrent lung cancer. Munagala R, Aqil F, Gupta RC. Tumour Biol; 2016 Aug 05; 37(8):10703-14. PubMed ID: 26867772 [Abstract] [Full Text] [Related]
19. Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins. Jansen FH, Krijgsveld J, van Rijswijk A, van den Bemd GJ, van den Berg MS, van Weerden WM, Willemsen R, Dekker LJ, Luider TM, Jenster G. Mol Cell Proteomics; 2009 Jun 05; 8(6):1192-205. PubMed ID: 19204029 [Abstract] [Full Text] [Related]
20. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Salo T, Vered M. J Cancer Res Clin Oncol; 2016 Jan 05; 142(1):101-10. PubMed ID: 26115960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]